Literature DB >> 18651249

Minimal traumatic brain injury induce apoptotic cell death in mice.

V Tashlykov1, Y Katz, A Volkov, V Gazit, S Schreiber, O Zohar, C G Pick.   

Abstract

In the United States, 1.4 million people suffer from traumatic brain injury (TBI) each year because of traffic, sports, or war-related injuries. The majority of TBI victims suffer mild to minimal TBI (mTBI), but most are released undiagnosed. Detailed pathologies are poorly understood. We characterized the microscopic changes of neurons of closed-head mTBI mice after increased unilateral trauma using hematoxylin and eosin (H&E) stain, and correlated it with the expression of the apoptotic proteins c-jun, p53, and BCL-2. Minimal damage to the brain increases the number of pyknotic appearing neurons and activates the apoptotic proteins in both hemispheres. Although minimal, increased impact was positively correlated with the increased number of damaged neurons. These results may explain the wide variety of behavioral and cognitive deficits closed-head mTBI causes in mice. Our cumulative results point to the pathological origin of post-concussion syndrome and may aid in the development of future neuroprotective strategies for the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651249     DOI: 10.1007/s12031-008-9094-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

Review 1.  Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases.

Authors:  Christophe Bonny; Tiziana Borsello; Azel Zine
Journal:  Rev Neurosci       Date:  2005       Impact factor: 4.353

Review 2.  Neuroproteomics in neurotrauma.

Authors:  Andrew K Ottens; Firas H Kobeissy; Erin C Golden; Zhiqun Zhang; William E Haskins; Su-Shing Chen; Ronald L Hayes; Kevin K W Wang; Nancy D Denslow
Journal:  Mass Spectrom Rev       Date:  2006 May-Jun       Impact factor: 10.946

Review 3.  Minor head injury: attempts at clarifying the confusion.

Authors:  M Y Kibby; C J Long
Journal:  Brain Inj       Date:  1996-03       Impact factor: 2.311

4.  Quality of Life after traumatic brain injury: A systematic review of the literature.

Authors:  Eva Berger; Friederike Leven; Nicola Pirente; Bertil Bouillon; Edmund Neugebauer
Journal:  Restor Neurol Neurosci       Date:  1999       Impact factor: 2.406

5.  Distribution of Fos- and Jun-related proteins and activator protein-1 composite factors in mouse brain induced by neuroleptics.

Authors:  T Ozaki; E Katsumoto; K Mui; D Furutsuka; S Yamagami
Journal:  Neuroscience       Date:  1998-06       Impact factor: 3.590

6.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

Review 7.  Experimental models of brain trauma.

Authors:  H L Laurer; T K McIntosh
Journal:  Curr Opin Neurol       Date:  1999-12       Impact factor: 5.710

Review 8.  The postconcussion syndrome after mild head trauma: is brain damage overdiagnosed? Part 1.

Authors:  S Margulies
Journal:  J Clin Neurosci       Date:  2000-09       Impact factor: 1.961

9.  Traumatic brain injury alters the molecular fingerprint of TUNEL-positive cortical neurons In vivo: A single-cell analysis.

Authors:  D M O'Dell; R Raghupathi; P B Crino; J H Eberwine; T K McIntosh
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

10.  DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injury.

Authors:  A Milman; O Zohar; R Maayan; R Weizman; C G Pick
Journal:  Eur Neuropsychopharmacol       Date:  2007-07-31       Impact factor: 4.600

View more
  32 in total

1.  A mouse model of blast-induced mild traumatic brain injury.

Authors:  Vardit Rubovitch; Meital Ten-Bosch; Ofer Zohar; Catherine R Harrison; Catherine Tempel-Brami; Elliot Stein; Barry J Hoffer; Carey D Balaban; Shaul Schreiber; Wen-Ta Chiu; Chaim G Pick
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

2.  Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.

Authors:  David Tweedie; Lital Rachmany; Dong Seok Kim; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Chaim G Pick; Nigel H Greig
Journal:  J Neurosci Methods       Date:  2016-02-08       Impact factor: 2.390

3.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

4.  Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury.

Authors:  L-Y Yang; Y-H Chu; D Tweedie; Q-S Yu; C G Pick; B J Hoffer; N H Greig; J-Y Wang
Journal:  Exp Neurol       Date:  2015-03-24       Impact factor: 5.330

5.  The neuroprotective effect of salubrinal in a mouse model of traumatic brain injury.

Authors:  Vardit Rubovitch; Shani Barak; Lital Rachmany; Renana Baratz Goldstein; Yael Zilberstein; Chaim G Pick
Journal:  Neuromolecular Med       Date:  2015-01-13       Impact factor: 3.843

6.  (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice.

Authors:  Daniela Lecca; Miaad Bader; David Tweedie; Alexander F Hoffman; Yoo Jin Jung; Shin-Chang Hsueh; Barry J Hoffer; Robert E Becker; Chaim G Pick; Carl R Lupica; Nigel H Greig
Journal:  Neurobiol Dis       Date:  2019-07-08       Impact factor: 5.996

7.  Dietary Energy Restriction Ameliorates Cognitive Impairment in a Mouse Model of Traumatic Brain Injury.

Authors:  V Rubovitch; A Pharayra; M Har-Even; O Dvir; M P Mattson; C G Pick
Journal:  J Mol Neurosci       Date:  2019-02-08       Impact factor: 3.444

8.  Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.

Authors:  Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

9.  Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Neurobiol Dis       Date:  2013-02-27       Impact factor: 5.996

10.  Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yazhou Li; Harold W Holloway; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Alzheimers Dement       Date:  2015-08-29       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.